BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29777006)

  • 1. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand
    Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT
    J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
    Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
    J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
    [No Abstract]   [Full Text] [Related]  

  • 3. In Vivo Comparison of Tau Radioligands
    Betthauser TJ; Lao PJ; Murali D; Barnhart TE; Furumoto S; Okamura N; Stone CK; Johnson SC; Christian BT
    J Nucl Med; 2017 Jun; 58(6):996-1002. PubMed ID: 27856627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [
    Guehl NJ; Wooten DW; Yokell DL; Moon SH; Dhaynaut M; Katz S; Moody KA; Gharagouzloo C; Kas A; Johnson KA; El Fakhri G; Normandin MD
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2099-2111. PubMed ID: 31332496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of
    Bullich S; Barret O; Constantinescu C; Sandiego C; Mueller A; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Madonia J; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):920-927. PubMed ID: 31712324
    [No Abstract]   [Full Text] [Related]  

  • 6. Tau PET imaging with
    Mueller A; Bullich S; Barret O; Madonia J; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):911-919. PubMed ID: 31712323
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo quantification of neurofibrillary tangles with [
    Pascoal TA; Shin M; Kang MS; Chamoun M; Chartrand D; Mathotaarachchi S; Bennacef I; Therriault J; Ng KP; Hopewell R; Bouhachi R; Hsiao HH; Benedet AL; Soucy JP; Massarweh G; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2018 Jul; 10(1):74. PubMed ID: 30064520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
    Lockhart SN; Baker SL; Okamura N; Furukawa K; Ishiki A; Furumoto S; Tashiro M; Yanai K; Arai H; Kudo Y; Harada R; Tomita N; Hiraoka K; Watanuki S; Jagust WJ
    PLoS One; 2016; 11(6):e0158460. PubMed ID: 27355840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatially constrained kinetic modeling with dual reference tissues improves
    Zhou Y; Flores S; Mansor S; Hornbeck RC; Tu Z; Perlmutter JS; Ances B; Morris JC; Gropler RJ; Benzinger TLS
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3172-3186. PubMed ID: 33599811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of 3 Novel Tau Radiopharmaceuticals,
    Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
    J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
    [No Abstract]   [Full Text] [Related]  

  • 14. [
    Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic Evaluation of the Tau PET Radiotracer
    Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
    J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
    [No Abstract]   [Full Text] [Related]  

  • 16. Dosimetry and efficacy of a tau PET tracer [
    Ohnishi A; Akamatsu G; Ikari Y; Nishida H; Shimizu K; Matsumoto K; Aita K; Sasaki M; Yamamoto Y; Yamane T; Senda M
    Ann Nucl Med; 2023 Feb; 37(2):108-120. PubMed ID: 36411357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of [
    Schmidt ME; Janssens L; Moechars D; Rombouts FJR; Timmers M; Barret O; Constantinescu CC; Madonia J; Russell DS; Sandiego CM; Kolb H
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3176-3185. PubMed ID: 32535652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ
    J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of
    Kuwabara H; Comley RA; Borroni E; Honer M; Kitmiller K; Roberts J; Gapasin L; Mathur A; Klein G; Wong DF
    J Nucl Med; 2018 Dec; 59(12):1877-1884. PubMed ID: 30097505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Strategies for Quantification of In Vivo
    Hahn A; Schain M; Erlandsson M; Sjölin P; James GM; Strandberg OT; Hägerström D; Lanzenberger R; Jögi J; Olsson TG; Smith R; Hansson O
    J Nucl Med; 2017 Apr; 58(4):623-631. PubMed ID: 27765859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.